337 related articles for article (PubMed ID: 17939062)
21. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.
Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM
Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118
[TBL] [Abstract][Full Text] [Related]
22. Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.
Niessen RC; Berends MJ; Wu Y; Sijmons RH; Hollema H; Ligtenberg MJ; de Walle HE; de Vries EG; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
Gut; 2006 Dec; 55(12):1781-8. PubMed ID: 16636019
[TBL] [Abstract][Full Text] [Related]
23. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
24. Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability.
Kets CM; van Krieken JH; Hebeda KM; Wezenberg SJ; Goossens M; Brunner HG; Ligtenberg MJ; Hoogerbrugge N
Br J Cancer; 2006 Dec; 95(12):1678-82. PubMed ID: 17117178
[TBL] [Abstract][Full Text] [Related]
25. Excess of extracolonic non-endometrial multiple primary cancers in MSH2 germline mutation carriers over MLH1.
Lin-Hurtubise KM; Yheulon CG; Gagliano RA; Lynch HT
J Surg Oncol; 2013 Dec; 108(7):433-7. PubMed ID: 24122742
[TBL] [Abstract][Full Text] [Related]
26. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
27. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.
Cederquist K; Emanuelsson M; Göransson I; Holinski-Feder E; Müller-Koch Y; Golovleva I; Grönberg H
Int J Cancer; 2004 Apr; 109(3):370-6. PubMed ID: 14961575
[TBL] [Abstract][Full Text] [Related]
28. Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome.
Froggatt NJ; Brassett C; Koch DJ; Evans DG; Hodgson SV; Ponder BA; Maher ER
J Med Genet; 1996 Sep; 33(9):726-30. PubMed ID: 8880570
[TBL] [Abstract][Full Text] [Related]
29. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
[TBL] [Abstract][Full Text] [Related]
30. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
31. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER
J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005
[TBL] [Abstract][Full Text] [Related]
32. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
[TBL] [Abstract][Full Text] [Related]
33. Microsatellite instability in early onset and familial colorectal cancer.
Brassett C; Joyce JA; Froggatt NJ; Williams G; Furniss D; Walsh S; Miller R; Evans DG; Maher ER
J Med Genet; 1996 Dec; 33(12):981-5. PubMed ID: 9004127
[TBL] [Abstract][Full Text] [Related]
34. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M
Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201
[TBL] [Abstract][Full Text] [Related]
35. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
[TBL] [Abstract][Full Text] [Related]
36. CHEK2 mutations and HNPCC-related colorectal cancer.
Suchy J; Cybulski C; Wokołorczyk D; Oszurek O; Górski B; Debniak T; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dziuba I; Gogacz M; Wiśniowski R; Wandzel P; Banaszkiewicz Z; Kurzawski G; Kładny J; Narod SA; Lubiński J
Int J Cancer; 2010 Jun; 126(12):3005-9. PubMed ID: 19876921
[TBL] [Abstract][Full Text] [Related]
37. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.
Charbonnier F; Olschwang S; Wang Q; Boisson C; Martin C; Buisine MP; Puisieux A; Frebourg T
Cancer Res; 2002 Feb; 62(3):848-53. PubMed ID: 11830542
[TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.
Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC
Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210
[TBL] [Abstract][Full Text] [Related]
39. Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing.
Park JG; Park YJ; Wijnen JT; Vasen HF
Int J Cancer; 1999 Aug; 82(4):516-9. PubMed ID: 10404064
[TBL] [Abstract][Full Text] [Related]
40. HNPCC: six new pathogenic mutations.
Kunstmann E; Vieland J; Brasch FE; Hahn SA; Epplen JT; Schulmann K; Schmiegel W
BMC Med Genet; 2004 Jun; 5():16. PubMed ID: 15217520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]